Literature DB >> 2077879

The effects of undigestible fructooligosaccharides on intestinal microflora and various physiological functions on human health.

H Hidaka1, M Hirayama, T Tokunaga, T Eida.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2077879     DOI： 10.1007/978-1-4684-5784-1_10

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  5 in total

1.  Short-chain fructooligosaccharides, in spite of being fermented in the upper part of the large intestine, have anti-inflammatory activity in the TNBS model of colitis.

Authors:  Federico Lara-Villoslada; Oscar de Haro; Desire Camuesco; Mónica Comalada; Javier Velasco; Antonio Zarzuelo; Jordi Xaus; Julio Galvez
Journal:  Eur J Nutr       Date:  2006-07-26       Impact factor: 5.614

2.  Bifidobacterium longum with fructo-oligosaccharides in patients with non alcoholic steatohepatitis.

Authors:  Michele Malaguarnera; Marco Vacante; Tijana Antic; Maria Giordano; Giuseppe Chisari; Rosaria Acquaviva; Silvana Mastrojeni; Giulia Malaguarnera; Antonio Mistretta; Giovanni Li Volti; Fabio Galvano
Journal:  Dig Dis Sci       Date:  2011-09-08       Impact factor: 3.199

3.  Chromatographic preparation of food-grade prebiotic oligosaccharides with defined degree of polymerization.

Authors:  Megan C Y Ooi; Xiaojie Zhang; Christopher M Beaudry; Juyun Lim; Michael H Penner
Journal:  Food Chem       Date:  2021-11-08       Impact factor: 7.514

4.  Bifidobacterium longum with fructo-oligosaccharide (FOS) treatment in minimal hepatic encephalopathy: a randomized, double-blind, placebo-controlled study.

Authors:  Mariano Malaguarnera; Filippo Greco; Gloria Barone; Maria Pia Gargante; Michele Malaguarnera; Maria Antonietta Toscano
Journal:  Dig Dis Sci       Date:  2007-03-28       Impact factor: 3.199

5.  Fructo-oligosaccharides and intestinal barrier function in a methionine-choline-deficient mouse model of nonalcoholic steatohepatitis.

Authors:  Kotaro Matsumoto; Mayuko Ichimura; Koichi Tsuneyama; Yuki Moritoki; Hiromichi Tsunashima; Katsuhisa Omagari; Masumi Hara; Ichiro Yasuda; Hiroshi Miyakawa; Kentaro Kikuchi
Journal:  PLoS One       Date:  2017-06-20       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.